50.4 Gy

RADIATION2 trials

Sponsors

Corporacion Parc Tauli

Conditions

Rectal CancerRectal Cancer Stage I

Phase 3

Preoperative Chemoradiotherapy and Transanal Endoscopic Microsurgery Versus Total Mesorectal Excision in T2-T3s N0, M0 Rectal Cancer

CompletedNCT01308190

Corporacion Parc TauliRectal Cancer

Start: 2010-08-31End: 2021-10-31Updated: 2021-11-23

Preoperative Chemoradiotherapy and Transanal Endoscopic Microsurgery Versus Ttransanal Endoscopic Microsurgery in T1 N0, M0 Rectal Cancer (TAUTEM-T1 Study)

Not yet recruitingNCT06450574

Corporacion Parc TauliRectal Cancer Stage I

Start: 2024-10-31End: 2027-10-31Target: 106Updated: 2024-06-10

Related Papers

Chemoradiotherapy and Local Excision vs Total Mesorectal Excision in T2-T3ab, N0, M0 Rectal Cancer: The TAUTEM Randomized Clinical Trial.

2025-07-015 citations

Short-term outcomes of chemoradiotherapy and local excision versus total mesorectal excision in T2-T3ab,N0,M0 rectal cancer: a multicentre randomised, controlled, phase III trial (the TAU-TEM study).

2022-10-0841 citations

Noninferiority multicenter prospective randomized controlled study of rectal cancer T2–T3s (superficial) N0, M0 (T2T3sN0M0) undergoing neoadjuvant treatment and local excision (TEM) versus total mesorectal excision (TME): Preoperative, surgical, and pathological outcomes—The TAUTEM-study.

Journal of Clinical Oncology2022-06-014 citations

Non-inferiority multicenter prospective randomized controlled study of rectal cancer T<sub>2</sub>-T<sub>3s</sub> (superficial) N<sub>0</sub>, M<sub>0</sub> undergoing neoadjuvant treatment and local excision (TEM) vs total mesorectal excision (TME).

2017-12-1221 citations